Researcher News & Insights

Researcher Audience Insights - “Continuing your studies”, Exploring intentions to take a postgraduate course among Researcher’s users.

The higher education system as we know it has considerably changed during the last 18 months, having to adapt to the varying nature of the pandemic. Some universities tried to offer a hybrid alternative, blending virtual lectures with in-person seminars; others, on the other hand, opted for full virtual semesters on platforms such as Zoom or Google Meet. Whether on a smaller or a larger scale, all university students have somehow experienced virtual learning and have seen their lives being turned upside down by the changes brought in by the pandemic.

Our mission to ensure scientists and researchers never miss vital research is more important than ever with the world facing the huge challenge of the COVID-19 pandemic. This challenge can only be solved through the work of scientists, academics, clinicians and economists across the world.

Researcher is launching the COVID-19 International Research Collaboration (CIRC) – a dedicated zone on the Researcher platform that provides the easiest way to follow the latest science on COVID-19.

If you’re a scientist, researcher, doctor, engineer, economist, journalist working on responses to COVID-19 - or perhaps you’re just interested - we want to make sure that staying up to the minute with the latest research and papers about COVID-19 is as easy as possible.
We want to make sure you never miss important papers that could change the course of your work and accelerate a breakthrough that could change lives - so we’re creating a series of resources to help you:

• We created The COVID-19 International Research Collaboration (CIRC). CIRC aggregates the papers that have the most engagement from the highest quality users on Researcher. The papers are split into the following themes: Vaccine, Drugs, Treatment, Drug Pathways, Sequencing, Economic Impact, Social Impact and Epidemiology.